Joshua White

Vice President at Analysis Group

Speaker

Mr. White is a consulting and testifying economist who specialises in applying microeconomics and sophisticated econometric modelling to complex litigation and merger-related questions, primarily in matters involving the pharmaceutical, health care, financial services, and technology industries. He has supported clients in various jurisdictions and industries in follow-on competition damages litigation, assessing overcharge, upstream and downstream pass-on, and volume effects. Mr. White has supported high-profile companies with complex merger reviews across multiple jurisdictions, including in the Veolia/Suez, LVMH/Tiffany, Sika/MBCC, and Eutelsat/OneWeb mergers.

Mr. White has worked in a number of jurisdictions, including the US, the UK, the European Union, Switzerland, Australia, New Zealand, South Africa, Canada, Japan, Korea, the Netherlands, and Belgium. He has served as a testifying expert in the UK Competition Appeal Tribunal (CAT) and the UK Upper Tribunal (Lands Chamber). He has also provided evidence to the UK’s Competition and Markets Authority (CMA) and the European Commission, including on behalf of clients involved in cartel investigations, abuse of dominance investigations, and mergers. He has supported numerous pharmaceutical clients in front of the CMA and the EC. Mr. White has also supported scientific and technical experts in front of the CAT and other courts and regulatory bodies throughout Europe, addressing competition and intellectual property issues for pharmaceutical clients. Mr. White regularly supports pharmaceutical clients on competition issues around market access, pricing, and competition from generic manufacturers. Mr. White is the author of a number of articles and regularly speaks at international competition law and policy conferences on the use of economics and econometrics in competition litigation and damages estimation.